tiprankstipranks
Invictus MD Strategies (IVITF)
OTHER OTC:IVITF

Invictus MD Strategies (IVITF) Stock Price & Analysis

96 Followers

IVITF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.01 - $0.01
Previous Close$0.01
Volume275.95K
Average Volume (3M)N/A
Market Cap
$4.59M
Enterprise Value$12.44M
Total Cash (Recent Filing)C$1.05M
Total Debt (Recent Filing)C$11.73M
Price to Earnings (P/E)N/A
Beta-83.75
Dec 30, 2019
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding124,583,163
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation19.64
R-Squared0.03
Alpha4.75
Financial Highlights & Ratios
Price to Book (P/B)1.53
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

23.58%0.00%0.02%76.41%
23.58%
Insiders
0.02% Other Institutional Investors
76.41% Public Companies and
Individual Investors

IVITF FAQ

What was Invictus MD Strategies’s price range in the past 12 months?
Invictus MD Strategies lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
    What is Invictus MD Strategies’s market cap?
    Currently, no data Available
    When is Invictus MD Strategies’s upcoming earnings report date?
    Invictus MD Strategies’s upcoming earnings report date is Dec 30, 2019 which is 1551 days ago.
      How were Invictus MD Strategies’s earnings last quarter?
      Invictus MD Strategies released its earnings results on Jun 28, 2019. The company reported -$0.029 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.029.
        Is Invictus MD Strategies overvalued?
        According to Wall Street analysts Invictus MD Strategies’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Invictus MD Strategies pay dividends?
          Invictus MD Strategies does not currently pay dividends.
          What is Invictus MD Strategies’s EPS estimate?
          Invictus MD Strategies’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Invictus MD Strategies have?
          Invictus MD Strategies has 124,583,160 shares outstanding.
            What happened to Invictus MD Strategies’s price movement after its last earnings report?
            Invictus MD Strategies reported an EPS of -$0.029 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Invictus MD Strategies?
              Currently, no hedge funds are holding shares in IVITF
              ---

              Invictus MD Strategies Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Company Description

              Invictus MD Strategies

              Invictus MD Strategies Corp. engages in the investment, acquisition, and development of licensed cannabis producers. Its activities include the cultivation and provision of cannabis products for medical use. The company was founded by Dan Kriznic on February 11, 2014 and is headquartered in Vancouver, Canada.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Cronos Group
              Canopy Growth
              Aurora Cannabis
              American Green
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis